Moderna’s new mRNA (messenger Ribonucleic Acid) flu shot completed the phase 3 trials with succeeding data. They are aiming to launch in early 2024. The flu vaccine – mRNA-1010 has produced an immune response against all four A and B strains – A/H1N1, A/H3N2, influenza B/Yamagata, and B/Victoria.
BiotechReality – News | Reports | Notes | Science
Explore the frontiers of Biotechnology, Pharma industry and Science with BiotechReality.com. We publish news, reports, and articles. We are exclusively publishing fellowship and studentship updates to light up the way for graduates to find a suitable research position in academia or industry.
JobFinder
Subscribe to Newsletter
Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.
BiotechReality.com
Contents in the website is licensed under CC BY-NC 4.0
Disclaimer: The content on this website is not meant to provide medical or any other professional advice. Understand and use the information, double check if necessary.